EMA Authorised: Voranigo (vorasidenib) — Les Laboratoires Servier

View source ↗

Summary

Voranigo (vorasidenib) has been authorised in the EU for oligodendroglioma and astrocytoma by Les Laboratoires Servier.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Oligodendroglioma

Drugs mentioned

• VORANIGO (VORASIDENIB)

Snippet

Status: Authorised. Therapeutic area: Oligodendroglioma;Astrocytoma. MAH: Les Laboratoires Servier. Decision date: 10/04/2026. Orphan medicine